NCT00523146已完成2 期
Treatment of Primary Dysmenorrhea With Kanion Capsule (GF) A Randomized, Double-blind, Placebo-controlled, Repeated-Dose and Multi-Center Clinical Phase II Trial
Lianyungang Kanion Group, Ltd.2 个研究点 分布在 1 个国家开始时间: 2007年4月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 试验地点
- 2
- 主要终点
- pain reduction
研究概览
简要总结
The objectives of this clinical trial are:
- To further study the safety of Kanion Capsule (GF) in primary dysmenorrhea subjects;
- To further evaluate the efficacy of GF in treatment of primary dysmenorrhea.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •primary dysmenorrhea
排除标准
- •secondary dysmenorrhea
结局指标
主要结局
pain reduction
时间窗: 6 months
次要结局
- accompanying symptoms improvement(6 months)
研究者
研究点 (2)
Loading locations...
相似试验
招募中
2 期
Effectiveness of Diquafosol Prophylactic Therapy to Prevent Dry Eye Disease for Cataract Surgery Patients in IndonesiaDry Eye DiseaseNCT06146881Indonesia University70
已完成
1 期
Clinic Trial in Phase 1 Using Amniotic Membrane for the Skin Replacement in Big WoundsWoundNCT01948934Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia6
招募中
3 期
Canakinumab for the Treatment of Postprandial HypoglycemiaPostprandial HypoglycemiaNCT05401578University Hospital, Basel, Switzerland56
已完成
2 期
Efficacy and Safety Study Comparing CPL409116 to Placebo in Participants With Active Rheumatoid ArthritisRheumatoid ArthritisNCT05374785Celon Pharma SA100
已完成
2 期
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac DiseaseCoeliac DiseaseCeliac DiseaseNCT06001177Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA55